These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23355353)

  • 41. Opsoclonus-myoclonus-ataxia syndrome associated with chikungunya and dengue virus co-infection.
    do Rosário MS; Giovanetti M; de Jesus PAP; Farias DS; Faria NR; de Lima CPS; da Silva SP; Nunes MR; Alcantara LCJ; de Siqueira IC
    Int J Infect Dis; 2018 Oct; 75():11-14. PubMed ID: 30076990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004.
    Sergon K; Njuguna C; Kalani R; Ofula V; Onyango C; Konongoi LS; Bedno S; Burke H; Dumilla AM; Konde J; Njenga MK; Sang R; Breiman RF
    Am J Trop Med Hyg; 2008 Feb; 78(2):333-7. PubMed ID: 18256441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meningoencephalitis Associated with Zika Virus and Chikungunya Virus Infection.
    de Almeida Oliveira Evangelista G; Hughes Carvalho R; Sant'Ana Menezes G; Carvalho de Abreu Y; Sardi SI; Soares Campos G
    Jpn J Infect Dis; 2021 Nov; 74(6):584-586. PubMed ID: 33952765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serological correlates of immune protection conferred by Chikungunya virus infection.
    Sheela PJ; Sumathy K
    Acta Virol; 2013; 57(4):471-3. PubMed ID: 24294963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seroprevalence, spatial dispersion and factors associated with flavivirus and chikungunha infection in a risk area: a population-based seroprevalence study in Brazil.
    Barreto FKA; Alencar CH; Araújo FMC; Oliveira RMAB; Cavalcante JW; Lemos DRQ; Farias LABG; Boriz ILF; Medeiros LQ; Melo MNP; Miyajima F; Siqueira AM; Freitas ARR; Cavalcanti LPG
    BMC Infect Dis; 2020 Nov; 20(1):881. PubMed ID: 33234110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and evaluation of baculovirus-expressed Chikungunya virus E1 envelope proteins for serodiagnosis of Chikungunya infection.
    Kumar P; Pok KY; Tan LK; Angela C; Leo YS; Ng LC
    J Virol Methods; 2014 Sep; 206():67-75. PubMed ID: 24880071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [[Virus-like particle-based immunoglobulin M capture enzyme-linked immunosorbent assay for the detection of IgM antibodies against Chikungunya virus].
    Li JD; Zhang QF; Zhang S; Li C; Liu QZ; Liang MF; Li DX
    Bing Du Xue Bao; 2014 Nov; 30(6):599-604. PubMed ID: 25868272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ocular involvement associated with an epidemic outbreak of chikungunya virus infection.
    Lalitha P; Rathinam S; Banushree K; Maheshkumar S; Vijayakumar R; Sathe P
    Am J Ophthalmol; 2007 Oct; 144(4):552-6. PubMed ID: 17692276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice.
    Arévalo MT; Huang Y; Jones CA; Ross TM
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007316. PubMed ID: 31026260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of Chikungunya fever in the Primorye Territory].
    Simakova AI; Popov AF; Sokotun SA; Sokotun OA; Petukhova SA
    Med Parazitol (Mosk); 2014; (4):54-5. PubMed ID: 25812416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outbreak of Chikungunya virus in the north Caribbean area of Colombia: clinical presentation and phylogenetic analysis.
    Mattar S; Miranda J; Pinzon H; Tique V; Bolanos A; Aponte J; Arrieta G; Gonzalez M; Barrios K; Contreras H; Alvarez J; Aleman A
    J Infect Dev Ctries; 2015 Oct; 9(10):1126-32. PubMed ID: 26517488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
    Fischer C; Bozza F; Merino Merino XJ; Pedroso C; de Oliveira Filho EF; Moreira-Soto A; Schwalb A; de Lamballerie X; Netto EM; Bozza PT; Sarno M; Brites C; Gotuzzo E; Talledo M; Drexler JF
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrospective investigation of antibodies against chikungunya virus (CHIKV) in serum from febrile patients in Mozambique, 2009-2015: Implications for its prevention and control.
    Antonio VS; Amade NA; Muianga AF; Ali S; Monteiro V; Mula F; Chelene I; Oludele J; Chongo I; José A; Augusto O; Gudo ES
    PLoS One; 2019; 14(3):e0213941. PubMed ID: 30897135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and Validation of a Rapid Lateral Flow E1/E2-Antigen Test and ELISA in Patients Infected with Emerging Asian Strain of Chikungunya Virus in the Americas.
    Reddy A; Bosch I; Salcedo N; Herrera BB; de Puig H; Narváez CF; Caicedo-Borrero DM; Lorenzana I; Parham L; García K; Mercado M; Turca AMR; Villar-Centeno LA; Gélvez-Ramírez M; Ríos NAG; Hiley M; García D; Diamond MS; Gehrke L
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32882998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic potential of monoclonal antibodies against the capsid protein of chikungunya virus for detection of recent infection.
    Damle RG; Jayaram N; Kulkarni SM; Nigade K; Khutwad K; Gosavi S; Parashar D
    Arch Virol; 2016 Jun; 161(6):1611-22. PubMed ID: 27016930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Four cases of acute flaccid paralysis associated with chikungunya virus infection.
    Singh SS; Manimunda SP; Sugunan AP; Sahina ; Vijayachari P
    Epidemiol Infect; 2008 Sep; 136(9):1277-80. PubMed ID: 18634716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
    Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
    Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Differential diagnosis of ataxia in childhood].
    Förster C; Förster CH
    Med Klin; 1976 Sep; 71(37):1508-11. PubMed ID: 958114
    [No Abstract]   [Full Text] [Related]  

  • 59. Analysis of antibody response (IgM, IgG, IgG3) to Chikungunya virus using panel of peptides derived from envelope protein for serodiagnosis.
    Verma P; Bhatnagar S; Kumar P; Chattree V; Parida MM; Hoti SL; Ali S; Rao DN
    Clin Chem Lab Med; 2014 Feb; 52(2):297-307. PubMed ID: 24088615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute cerebellar ataxia: a rare Toscana Virus (TOSV) meningoencephalitis complication.
    Suardi LR; Di Lauria N; Pozzi M; Rogasi PG; Barilaro A; Azzolini F; Prestipino E; Colao MG; Rossolini GM; Bartoloni A
    Int J Neurosci; 2020 Mar; 130(3):276-278. PubMed ID: 31554442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.